News

benzinga_article
2026.01.08 16:57
RenovoRx shares are trading higher. The company announced that it will present a new clinical data abstract from a pharmacokinetic and pharmacodynamic sub‑study of its ongoing Phase III TIGeR‑PaC clinical trial at the ASCO GI.